Provided by Tiger Trade Technology Pte. Ltd.

SINO BIOPHARM

5.870
-0.060-1.01%
Volume:15.64M
Turnover:92.36M
Market Cap:110.13B
PE:30.68
High:5.990
Open:5.930
Low:5.860
Close:5.930
52wk High:9.120
52wk Low:3.137
Shares:18.76B
HK Float Shares:18.76B
Volume Ratio:0.87
T/O Rate:0.08%
Dividend:0.09
Dividend Rate:1.60%
EPS(LYR):0.191
ROE:15.40%
ROA:5.07%
PB:2.92
PE(LYR):30.68
PS:3.18

Loading ...

Clinical Trial for SINO BIOPHARM's (01177) TQB3205 Pan-KRAS Inhibitor Receives NMPA Approval

Stock News
·
Mar 11

Sino Biopharmaceutical wins NMPA clinical trial approval for pan-KRAS inhibitor TQB3205

Reuters
·
Mar 11

SINO BIOPHARM (01177) Secures NMPA Green Light for Clinical Trial of Pan-KRAS Inhibitor TQB3205

Bulletin Express
·
Mar 11

Sino Biopharmaceutical - Tqb3205 Pan-Kras Inhibitor Receives Nmpa Clinical Trial Approval for Advanced Malignant Tumors

THOMSON REUTERS
·
Mar 11

Sino Biopharmaceutical Stock Falls 1.3% in Hong Kong

Dow Jones
·
Mar 11

Assessing Sino Biopharmaceutical (SEHK:1177) Valuation After Sanofi Rovadicitinib Licensing Agreement

Simply Wall St.
·
Mar 09

Sino Biopharmaceutical Stock Climbs 3.5% in Hong Kong, Outperforms Competitors

Dow Jones
·
Mar 05

Hong Kong Healthcare Stocks Rebound Strongly: Innovative Drug ETF Surges Over 3%

Deep News
·
Mar 05

Stock Track | SINO BIOPHARM Soars 6.83% Intraday on $1.53 Billion Licensing Deal with Sanofi

Stock Track
·
Mar 05

SINO BIOPHARM Shares Surge Over 5% on $1.53 Billion Licensing Deal with Sanofi for Rovadicitinib

Stock News
·
Mar 05

Antengene, Sino Biopharmaceutical Shares Jump After New Drug Licensing Deals

Dow Jones
·
Mar 04

Sino Biopharmaceutical Limited (1177) Announces Exclusive License Agreement with Sanofi

Bulletin Express
·
Mar 04

Sino Biopharm Inks Exclusive Licensing Deal with Sanofi for Rovadicitinib

Stock News
·
Mar 04

Sino Biopharmaceutical Licenses ROVADICITINIB to Sanofi in Exclusive Global Deal

Reuters
·
Mar 04

Sino Biopharmaceutical - Exclusive License Agreement for Rovadicitinib With Sanofi

THOMSON REUTERS
·
Mar 04

Sino Biopharmaceutical - Sales Milestone Payments of up to US$1,395 Mln

THOMSON REUTERS
·
Mar 04

Sino Biopharmaceutical - Group Is Eligible to Receive an Upfront Payment of US$135 Mln

THOMSON REUTERS
·
Mar 04

Sino Biopharmaceutical Stock Slips 2.8% in Hong Kong

Dow Jones
·
Mar 02

Sino Biopharmaceutical (01177) Publishes February 2026 Monthly Return, No Change to Issued Shares

Bulletin Express
·
Mar 02

Sino Biopharmaceutical Limited (1177) Announces Approval of Rovadicitinib Tablet

Bulletin Express
·
Mar 02